Loading Events
K-CONNECT SUMMIT 2026
Experts Meeting

K-CONNECT SUMMIT 2026

AI & Multi-omics – Shifting Paradigms in the New Era of Early Cancer Detection and Precision Oncology 

The 2026 Summit is designed as a high-level academic forum bringing together regional and international leaders to discuss how ctDNA, multi-omics, AI integration, and comprehensive genomic profiling can be translated into structured, real-world oncology practice across the Asia-Pacific region. 

K-CONNECT is part of the broader K-CONNECT PLATFORM, a regional initiative pioneered by Gene Solutions to connect oncologists, researchers, and healthcare professionals across Asia-Pacific. The platform is dedicated to fostering practical knowledge exchange, accelerating collaborative research, and driving innovation in cutting-edge fields including ctDNA (circulating tumor DNA)–MRD (Minimal Residual Disease) and Comprehensive Genomic & Transcriptomic Profiling (CGTP). 

Through this summit, we aim to strengthen regional collaboration and advance the clinical implementation of precision oncology, particularly in integrating molecular data into routine screening, diagnosis, treatment decision-making, and disease monitoring.

Days
Hours
Minutes
Seconds
The event has ended. Thank you for your participation.

K-CONNECT APAC 2025

EMPOWERING THE POTENTIAL OF ctDNA-MRD

gs favicon - The K-CONNECT Platform

Gene Solutions, JSC

Gene Solutions envisions elevating healthcare in Asia through multi-dimensional genomics and AI, committed to accessible genetic testing services.

LIBRARY

No downloads found!
No downloads found!

Upcoming videos will be released shortly

AGENDA

| K-CONNECT SUMMIT 2026

May 8
Day 01
Arrival and Welcome Reception​
May 9
Day 02
Academic Day​
08:00 – 09:00
Networking Activation​
09:00 – 09:30
Opening
Professor
The Chinese University of Hong Kong​
  • Gene Solutions Introduction
  • Opening Speech
09:30 – 10:45
SESSION I: EARLY CANCER DETECTION (ECD)

Theme: ctDNA & AI – The Paradigm Shift in Early Cancer Screening in Modern Medicine

Doctor
Medical Genetics Institute, Vietnam​​
Integrating AI Capabilities and Multi-omics ctDNA Analysis in Multi-Cancer Screening ​
Bridging the gap in genomic insights across the Asia-Pacific region
The Clinical Utility of ctDNA in Early Cancer Screening: Clinical Evidence & Real-world Practice​
Professor
The Chinese University of Hong Kong​

Cancer Screening in Modern Medicine: ctDNA Applications & Health Economic Perspectives

Panel Discussion – Early Cancer Detection
10:45 – 11:00
Coffee Break
11:00 – 12:30
SESSION II: EVIDENCE AND CLINICAL VALIDITY

Theme: Global Trends in Cancer Management: The Role of ctDNA and Comprehensive Genomic and Transcriptomic Profiling ​

Doctor
Principal Investigator, Gene Solutions
Multi-omics and AI in ctDNA Monitoring & CGTP: Technological Perspectives and Clinical Applications
Bridging the gap in genomic insights across the Asia-Pacific region
Comprehensive Genomic Profiling and ctDNA monitoring: Clinical Insights and Applications Across Solid Tumors
Associate Professor
University Medical Center, Ho Chi Minh City
Lung Cancer Clinical Case: Concurrent RNA and DNA Sequencing​
Bridging the gap in genomic insights across the Asia-Pacific region
Gastrointestinal Cancer Clinical Case: The Role of ctDNA, TMB, and MSI-H in Treatment Selection​
Panel Discussion – Evidence & Clinical Validity
12:30 – 13:00
Lunch Break
12:45 – 13:45
Lung Cancer Session: ctDNA-MRD Applications & Real-World Cases Sharing
Associate Professor
University Medical Center, Ho Chi Minh City
Clinical Utility of ctDNA-MRD in NSCLC: Real-World Insights and Case Applications​
Associate Professor
Chulalongkorn University, Thailand
Real-World Application of ctDNA-MRD in Early-Stage Lung Adenocarcinoma: Two Clinical Case Analyses​
Associate Professor
National Referral for Repiratory diseases, RSUP Persahabatan
Personalizing NSCLC Follow-Up and Treatment with ctDNA-MRD: Lessons from Practice​
Q&A session
13:45 – 13:55
Coffee Break
13:55 – 14:55
Breast Cancer Session: ctDNA-MRD Applications & Real-World Cases Sharing
Professor
Chaophya Hospital, Thailand
Real-World Evidence for ctDNA-MRD in Breast Cancer Management​
Doctor
Siloam MRCCC, Jakarta, Indonesia
Harnessing ctDNA-MRD to Guide Complex Treatment Decisions in Advanced HER2+ Breast Cancer​
Q&A session
14:55 – 15:25
Next Landmark In Genomic Profiling & ctDNA
Professor
The University of Hong Kong
Genetic Testing Guided Personalized Immunotherapy in Refractory Solid Tumors: A Phase II Randomized Clinical Trial
MSc, BSc
Global Medical Affairs Director, Gene Solutions
Triad of Impact– A Multi-omic Solution to Advance Precision Oncology Innovation
Q&A session
15:25 – 15:30
Closing Remarks

SPEAKERS & PANELISTS

Professor

University of Sydney, Australia

Associate Professor

National Referral for Repiratory diseases, RSUP Persahabatan

Doctor

Siloam MRCCC, Jakarta, Indonesia

Professor

Vice President, Vietnam Society for Oncology Immunotherapy, Vietnam

Associate Professor

University Medical Center, Ho Chi Minh City

Associate Professor

Hong Ngoc Hospital – Phuc Truong Minh, Vietnam

Doctor

Chiangmai Ram Hospital, Thailand

Associate Professor

Chulalongkorn University, Thailand

Professor

Chaophya Hospital, Thailand

Doctor

St. Lukes BGC

Doctor

President of Hong Kong Precision Oncology Society, Hong Kong

Professor

Center of Cancer Medicine, The University of Hong Kong

Professor

The University of Hong Kong

Doctor

Medical Oncologist, Oncology Medical Director, Gene Solutions

Professor

The Chinese University of Hong Kong​

Doctor

Medical Genetics Institute, Vietnam​​

Professor Assistant

National Cancer Centre Singapore

Bridging the gap in genomic insights across the Asia-Pacific region

Doctor

Principal Investigator, Gene Solutions

MSc, BSc

Global Medical Affairs Director, Gene Solutions
ONLINE RESOURCES

CASE STUDIES

K-CONNECT APAC 2025